A groundbreaking collaboration between Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and the Frederick National Laboratory for Cancer Research is revolutionizing cancer treatment and supercomputer-aided drug discovery. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more: https://livermorelab.info/3yXVa0e | Lawrence Livermore National Laboratory
3:30
FacebookLawrence Livermore National Laboratory
A groundbreaking collaboration between Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and the Frederick National Laboratory for Cancer Research is
Lawrence Livermore National Laboratory. . A groundbreaking collaboration between Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and the Frederick National Laboratory for Cancer Research is revolutionizing cancer treatment and supercomputer-aided drug discovery. Explore how this pioneering effort could accelerate the ...
2K viewsJun 6, 2024
Related Products
Acoramidis Bridgebio
Acoramidis Package Bridgebio
Acoramidis with Bridgebio
#BridgeBio Research
ResearchBridge
ResearchBridge
devpost.comJan 13, 2025
BridgeBio Pharma Expands Research into Neuromuscular Disease to Include Limb-Girdle Muscular Dystrophy Type 2 with New Subsidiary ML Bio Solutions
BridgeBio Pharma Expands Research into Neuromuscular Disease to Include Limb-Girdle Muscular Dystrophy Type 2 with New Subsidiary ML Bio Solutions
marketscreener.comSep 5, 2019
Top videos
EP 212: A hub-and-spoke model for accelerating rare disease drug development with BridgeBio
48:37
EP 212: A hub-and-spoke model for accelerating rare disease drug development with BridgeBio
YouTubeSano Genetics
74 views4 months ago
BridgeBio Oncology Therapeutics Rings the Closing Bell
BridgeBio Oncology Therapeutics Rings the Closing Bell
nasdaq.com
5 months ago
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
Instagramlivermore_lab
5K viewsJun 6, 2024
BridgeBio Clinical Trials
Calibrate Bio | Clinical Trial Intelligence for Pharma & Finance | Sebastian D. | 16 comments
Calibrate Bio | Clinical Trial Intelligence for Pharma & Finance | Sebastian D. | 16 comments
linkedin.com
3 months ago
Are you living with type 2 diabetes, overweight and high blood sugar/HbA1c levels? You may qualify for our clinical trial and could receive: ✔ Study-related care ✔ A chance to help with medical research Learn more and see if you qualify. | Trialbee Clinical Trials
0:11
Are you living with type 2 diabetes, overweight and high blood sugar/HbA1c levels? You may qualify for our clinical trial and could receive: ✔ Study-related care ✔ A chance to help with medical research Learn more and see if you qualify. | Trialbee Clinical Trials
FacebookTrialbee Clinical Trials
40.6K views4 months ago
❓ How can biotechnology companies navigate endpoint challenges in clinical trials? Join Clario’s webinar with Dr. Todd Rudo, Chris Clendening, and John Ohrn to learn best practices for selecting the right clinical trial endpoints, optimizing trial design, and leveraging innovative technologies. Gain insights into accelerating your path to approval and ensuring regulatory success. Register now: https://buff.ly/7aou8bZ #ClinicalTrials #Biotech #TrialDesign #EndpointStrategy #DrugDevelopment #Webin
0:35
❓ How can biotechnology companies navigate endpoint challenges in clinical trials? Join Clario’s webinar with Dr. Todd Rudo, Chris Clendening, and John Ohrn to learn best practices for selecting the right clinical trial endpoints, optimizing trial design, and leveraging innovative technologies. Gain insights into accelerating your path to approval and ensuring regulatory success. Register now: https://buff.ly/7aou8bZ #ClinicalTrials #Biotech #TrialDesign #EndpointStrategy #DrugDevelopment #Webin
FacebookXtalks Webinars
25K views10 months ago
EP 212: A hub-and-spoke model for accelerating rare disease drug development with BridgeBio
48:37
EP 212: A hub-and-spoke model for accelerating rare disease drug dev…
74 views4 months ago
YouTubeSano Genetics
BridgeBio Oncology Therapeutics Rings the Closing Bell
BridgeBio Oncology Therapeutics Rings the Closing Bell
5 months ago
nasdaq.com
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for s…
5K viewsJun 6, 2024
Instagramlivermore_lab
Sun-Gou Ji - computational genomics for drug development
43:35
Sun-Gou Ji - computational genomics for drug development
1 month ago
YouTubeThe Bioinformatics CRO
EP 212: A hub-and-spoke model for accelerating rare disease drug development with Ananth Sridhar ...
46:06
EP 212: A hub-and-spoke model for accelerating rare disease drug dev…
24 views3 months ago
YouTubeSano Genetics
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
LLNL and BridgeBio announce trials for supercomputing-discovered ca…
5 months ago
llnl.gov
How BridgeBio Transformed Compliance With Egnyte’s GxP Compliant Platform
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP Co…
114 views10 months ago
YouTubeEgnyte
1:13:13
Ep190: Neil Kumar on Building a Rare Disease Drug Company
63 views3 months ago
YouTubeThe Long Run with Luke Timmerman
2:48
BridgeBio CEO Neil Kumar: Our heart disease drug staves off deat…
1.5K viewsJan 14, 2025
YouTubeCNBC Television
33:05
BridgeBio Oncology Therapeutics (BBOT) @ JPM 2026 第44届摩根大 …
28 views2 months ago
bilibilibili_42520431755
BridgeBio bondit en Bourse après des résultats « idéaux » pour son t…
4 months ago
zonebourse.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
138 views7 months ago
YouTubeMelissa Bime
1:34
Meet the PAL – Larizza
45 views5 months ago
YouTubeBridgeBio
1:05
Meet the PAL – Justin
60 views5 months ago
YouTubeBridgeBio
The News That Could Stoke BridgeBio, Up 80% This Year
5 months ago
investors.com
12:07
[바이오팟동영상] 브릿지바이오 이정규 대표 - Bridge Biotherapeutics, Inc.
701 viewsJun 19, 2017
YouTube뉴스1TV
11:29
Break Bio
13 views6 months ago
YouTubeRoger Royse Law
1:07
Meet the PAL – Rich
65 views5 months ago
YouTubeBridgeBio
1:01:15
Founder Stories: Neil Kumar - founder and CEO of BridgeBio
2.7K viewsJun 14, 2020
YouTubeAxial
8:32
Putting Patients First: BridgeBio Founder & CEO, Neil Kumar, Ph.D…
758 views10 months ago
YouTubeBridgeBio
0:17
LGMD2I/R9 can’t be diagnosed based on symptoms alone. It requi…
103 views4 months ago
FacebookBridgeBio
1:07
FIRST POTENTIAL TREATMENT FOR GENETIC MUSCULAR DYSTR…
6 views4 months ago
YouTubeHealth Haven
7:17
BridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu Trial
3 weeks ago
YouTubeBioMed Nexus
1:58
Mechanism of disease of LGMD2I/R9
274 views4 months ago
YouTubeBridgeBio
38:53
On Rare Innovators: Kat Bryant Knudson and Reimagining Collab…
35 views1 week ago
YouTubeBridgeBio
45:16
Academia + Industry with BridgeBio's Dr. Michael Henderson
583 viewsJun 21, 2021
YouTubeLife Science Connect
11:06
From Personal Journey to Lifelong Mission: Carmen’s Story
1.7K views3 months ago
YouTubeBridgeBio
1:10
Meet the PAL – Cynthia
55 views5 months ago
YouTubeBridgeBio Pharma
4:06
Living with LGMD2i
569 viewsNov 24, 2024
YouTubeBridgeBio
See more videos
Static thumbnail place holder